Tower Cancer Research Foundation’s Magnolia Council Spirit of Hope Luncheon Benefits Research, Patient & Survivor Support
Posted: Friday, October 20, 2017 – 3:49 PM
Last week, more than over 600 women and leaders in entertainment, politics, business and medicine attended Tower Cancer Research Foundation’s (TCRF) Magnolia Council Spirit of Hope Luncheon & Boutique at The Beverly Wilshire in Beverly Hills to honor philanthropist and President of the Magnolia Council, Beth Goren, and surgeon Dr. Jay Orringer. More than $500,000 was raised at the event.
Since its inception in 2009, The Magnolia Council has raised more than $2 million dollars. The group of women community leaders supports Tower’s mission by generating broader community awareness through expanded social and fundraising events. The Magnolia Council awards an annual $100,000 research grant to a young physician scientist in Southern California. In addition, the council helps fund Tower’s patient support programs, Magnolia House, an integrative survivorship wellness center with in-depth programs offered at no cost to cancer survivors and their loved ones. The goal of Magnolia House is to help participants develop a physical and emotional toolkit to manage the challenges of the disease. To that end, Tower’s Magnolia House programs offers a host of weekly support workshop series and private, individually tailored experiences such as a one-on-one fitness training with a cancer-trained therapist.
• Beth Goren first became a member of the Magnolia Council in 2009 and began serving as the Magnolia President in 2015. She also sits on the TCRF board of directors and is an active volunteer on multiple Tower committees. She is proud to be a part of Tower, alongside volunteers and members working to raise funds for cancer research. In addition to her time spent working to find a cure, Goren serves on the Executive Camp Committee of Wilshire Boulevard Temple Camps and was the president of the Parent Organization Board for Heschel Day School while her children were in attendance. Beth received her B.A. and Lifetime Teaching Credential from UCLA. She taught at Temple
Emanuel Day School and was an infant/toddler teacher at Valley Beth Shalom for 28 years.
• As an internationally-recognized leader in the field of surgery and in particular, breast reconstruction, Dr. Jay Orringer has spent time developing an algorithmic approach for optimizing aesthetic mastectomy incisions. Orringer has published on a variety of surgical topics and has lectured nationally at both the Breast and Body Contouring Symposium as well as at the annual meeting of the American Society of Plastic Surgeons. In recent years, a Compassionate Care Symposium was named in Dr. Orringer’s honor. As a testament to Orringer’s understanding of, and impact upon, his cancer patients, and his ability to inspire hope in his patients, TCRF honored him with its Spirit of Hope Award this year.
The Magnolia Council Spirit of Hope Luncheon is designed to bring attention to the accomplishments of the honorees and raise funding for TCRF. Over the last 20 years, Tower has raised more than $30 million—resources that have funded specific research and patient support programs that are professionally vetted by committees comprised of local scientific and community leaders. In addition, Tower awards several $100,000 grants annually to young pioneering physician scientists engaged inbench-to-bedside research. In the last two decades, Tower has participated in more than clinical trials with thousands of patients and awarded more than $3 million to 32 physician scientists pursuing novel hypotheses. While there are many scientists performing cancer research, Tower recognizes the importance of nurturing the regional pool of rich research talent because important breakthroughs have come from unexpected directions and provided new perspectives. The physician scientists who have received Tower’s Career Development Grants often demonstrate such promising results that they later obtain large grants from other foundations and cancer research centers. Tower’s initial $3 million investment has led to $35 million in additional clinical research funding. http://towercancer.org.